Pharmaceutical care of patients after splenectomy under different surgical methods

WANG Chunling; SHAN Xuechun; WANG Zhuo; JIN Gang; ZHENG Kailian; DING Nan

PDF(1263 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2025, Vol. 36 ›› Issue (8) : 645-649.

ORIGINAL ARTICLES

Pharmaceutical care of patients after splenectomy under different surgical methods

WANG Chunling^1,2, SHAN Xuechun³, WANG Zhuo¹, JIN Gang⁴, ZHENG Kailian⁴, DING Nan¹

Author information +

History +

Abstract

Objective To explore the key points of pharmaceutical care for patients after splenectomy under different surgical methods, and to provide useful reference information for clinical practice. Methods Based on the differences of the range of organ resection, reconstruction methods of the digestive tract, and incidence of postoperative complications of different pancreatic surgical methods, Clinical pharmacists selected three typical patients who had pancreatic fistula, abdominal infection, and blood glucose disorders after pancreaticoduodenectomy, distal pancreatectomy, and total pancreatectomy. By monitoring the amylase and drainage volume of the drainage fluid, postoperative pancreatic fistula could be treated. Attention was paid to the changes in various infection indicators and microbial culture results to adjust the anti-infection plan. Postoperative blood glucose changes were monitored and appropriate medication was given in a timely manner. The pharmaceutical care practice was combined with relevant literature to extract and analyze the key points of postoperative care under different surgical methods by combining. Results After pharmaceutical care by clinical pharmacists, the patient’s postoperative complications were controlled, and they were discharged in good condition. Conclusions Clinical pharmacists should should care patients after pancreatic surgery based on the surgical methods to improve the effectiveness and safety of treatment.

Key words

pancreatic tumors / abdominal infection / splenectomy / abnormal blood sugar / pharmaceutical care

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WANG Chunling, SHAN Xuechun, WANG Zhuo, JIN Gang, ZHENG Kailian, DING Nan. Pharmaceutical care of patients after splenectomy under different surgical methods[J]. Medical Journal of the Chinese People Armed Police Forces. 2025, 36(8): 645-649

References

[1] 中华医学会胰腺外科学组.胰腺术后外科常见并发症防治指南(2022)[J].中华外科杂志,2023,61(7):529-534.
[2] 程晟,罗晓,温爱萍,等.临床药师参与174例腹腔感染会诊分析[J].中国医院用药评价与分析,2022,22(9):1138-1141.
[3] 汤承基,周佳,宋颖辉,等.胰腺外分泌功能不全的病因、诊断及治疗进展[J].中国普通外科杂志,2025,34(3):572-578.
[4] 林云钗,彭峰,周强,等.2型糖尿病患者肠道菌群变化与胰腺内分泌激素的相关性[J].中华高血压杂志,2020,28(12):1157-1162.
[5] 姜洪池,周孟华.脾脏外科临床研究进展与展望[J].中国实用外科杂志,2020,40(1):53-57,61.
[6] 林志谦,林淑婷.脾切除术后胰瘘影响因素分析及预测模型构建[J].腹部外科,2024,37(3):216-220.
[7] 楼颂羔,徐领城,李雷清,等.451例复杂性腹腔感染患者抗菌药物临床应用状况分析[J].中华急诊医学杂志,2019,28(5):609-613.
[8] 姚沣轩,李国光,向兴华,等.腹腔镜脾脏部分切除术的安全性及疗效[J].中国普通外科杂志,2023,32(1):154-158.
[9] Kristinsson S Y,Gridley G,Hoover R N,et al.Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up[J].Haematologica,2014,99(2):392-398.
[10] Rankine-Mullings A E,Owusu-Ofori S.Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease[J].Cochrane Database Syst Rev,2017,10(10):CD003427.
[11] Hu P,Li X,Lu N,et al.Prediction of new-onset diabetes after pancreatectomy with subspace clustering based multi-view feature selection[J].IEEE J Biomed Health Inform,2023,27(3):1588-1599.
[12] Hamad A,Hyer J M,Thayaparan V,et al.Pancreatogenic diabetes after partial pancreatectomy: a common and understudied cause of morbidity[J].J Am Coll Surg,2022,235(6):838-845.
[13] 崔蕾,刘玲珑,王剑剑,等.胰腺切除患者围术期血糖管理的最佳证据总结[J].中国全科医学,2022,25(9):1047-1053.
[14] 文侃. 基于CT定量评估的胰腺良性病变切除体积与术后高血糖相互关系的研究[D].华中科技大学,2021.
[15] Firkins S A, Hart P A, Porter K,et al.Incidence and risk factors for new-onset diabetes mellitus after surgical resection of pancreatic cystic lesions: a marketscan study[J].Pancreas,2022,51(5):427-434.
[16] 贺晓颖,卞丽芳,郭雪娥,等.胰腺术后新发糖尿病危险因素与预测模型的研究进展[J].护理与康复,2025,24(2):88-92.
[17] 洪冬梅,戴爱兰.围术期高血糖管理[J].科学生活,2024,(1):62-63.
[18] 蔡正华,杨翼飞,包善华,等.胰腺术后胰源性糖尿病研究进展[J].腹部外科,2021,34(5):396-399.
[19] 马倩,陈海燕,徐国徽,等.胰腺切除术后胰瘘基于CT及临床特征的术前预测及风险评估[J/OL].肝胆胰外科杂志(2025-05-14)[2025-05-20].http://122.51.45.239:8085/kcms/detail/33.1196.R.20250513.1721.006.html.
[20] Liu X,Chen K,Chu X,et al.Prophylactic intra-peritoneal drainage after pancreatic resection: an updated meta-analysis[J].Front Oncol,2021,20(11):658829.
[21] 周嘉杰,梁文祥,马宇斐,等.腹腔镜胰十二指肠切除术后胰瘘的临床防治进展[J].肝胆外科杂志,2024,32(6):476-480.
[22] Li L,Xu L,Zhu R,et al.Effect of prior receipt of antibiotics on the pathogen distribution: a retrospective observational cohort study on 27792 patients[J].BMC Infectious Diseases,2020,20:1-10.
[23] 邱清容. 脾切除术围术期抗菌药物应用调查分析[J].中国医药科学,2021,11(8):155-158.
[24] 文雪刚,毛青松,龚建平.肝硬化脾切除术后门静脉血栓形成的预防研究进展[J].中国现代普通外科进展,2023,26(3):242-244.
[25] 徐建威,王磊.保留脾脏的胰体尾切除术研究进展[J].中国实用外科杂志,2023,43(2):206-210,215.
[26] 林婧格,白洁.血糖变异性对糖尿病慢性并发症影响及机制的研究进展[J].中国糖尿病杂志,2023,31(7):547-550.